Molecular mechanisms of myocardial remodeling. The role of aldosterone

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 12, 2002, Pages 1577-1584

  Delcayre, Claude ^a   Swynghedauw, Bernard ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Aldosterone; Cardiac remodeling; Evolutionary medicine; Fibrosis; Heart failure; Myocardial infarction; Renin angiotensin system

Indexed keywords

ALDOSTERONE; ALDOSTERONE RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; LOSARTAN; SPIRONOLACTONE; TRANSCRIPTION FACTOR;

ADAPTATION; COLLAGEN SYNTHESIS; HEART ATRIUM; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HIGH POTASSIUM INTAKE; HIGH SODIUM INTAKE; HORMONAL REGULATION; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0036911129     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2088     Document Type: Review

References (51)

1. Lompré AM, Schwartz K, D'Albis A, Lacombe G, Thiem NV, Swynghedauw B. Myosin isozymes redistribution in chronic heart overloading. Nature 1979; 282: 105-107.
2. Alpert NR, Mulieri LA, Hasenfuss G. Myocardial chemo-mechanical energy transduction. In: HA Fozzard, E Haber, AM Katz, R Jennings. H Morgan (ed.) The Heart and Cardiovascular System 1992. New York: Raven Press, 111-128.
3. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999, 79, 215-262.
4. Swynghedauw B, Baillard C. Biology of hypertensive cardiopathy. Cur Opinion Cardiol 2000. 15, 247-253.
5. Weber KT, Aldosterone on congestive heart failure. N Engl J Med 2001; 345: 1689-1697.
6. Delcayre C, Silvestre JS, Granier A, Oubenaissa A, Cailmail S, Tatara E, Swynghedauw B, Robert V. Cardiac aldosterone production and ventricular remodeling. Kidney Internat 2000; 57: 1346-1351.
7. 2+ATPase and calsequestrine genes in rat heart during ontogenic development and ageing. Circ Res 1991; 69: 1380-1388.
8. Assayag P, Charlemagne D, Marty I, De Leiris J, Lompré AM, Boucher F, Valère PE, Lortet S, Swyghedauw B, Besse S. Effects of low-flow ischemia on myocardial function and calcium-regulating proteins in adult and senescent rat hearts. Cardiovasc Res 1998, 38. 169-180.
9. Trevathan WR, Smith EO, Mckenna JJ (eds) Evolutionary Medicine 1999. New York: Oxford University Press, USA.
10. +)-ATPase subunit mRNA and protein levels in hypertrophied heart. J Biol Chem 1994; 269: 1541-1547.
11. Besse S, Delcayre C, Chevalier B, Hardouin S, Heymes C, Bourgeois F, Moalic JM, Swynghedauw B. Is the senescent heart overloaded and already failing? A review. Cardiovasc Drug Ther 1994; 8: 581-587.
12. 2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514.
13. Marsh JD. Coregulation of calcium channels and beta-adrenergic receptors in cultured chick embryo ventricular ceils. J Clin Invest 1989; 84: 817-823.
14. 2+ current in adult rat cardiomyocytes. Circ Res 1999; 85: 1139-1145.
15. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990; 67: 1355-1364.
16. Robert V, Thiem NV, Cheav SL, Mouas C, Swynghedauw B, Delcayre C. Increased cardiac types (I) and (III) collagen mRNAs in aldosterone-salt hypertension. Hypertension 1994; 24: 30-36.
17. Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 1995; 269: E657-E662.
18. Robert V, Silvestre JS, Charlemagne D, Sabri A, Trouvé P, Wassef M, Swynghedauw B, Delcayre C, Biological determinants of aldosterone-induced cardiac fibrosis in rat. Hypertension 1995; 26: 971-978.
19. Robert R, Besse S, Sabri A, Silvestre JS, Assayag P, Thiem NV, Swynghedauw B, Delcayre C. Differential regulation of Matrix MetalloProteinases associated with ageing and hypertension in the rat heart. Lab Invest 1997; 76: 729-738.
20. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26: 809-820.
21. Fullerton MJ, Funder JW. Aldosterone and cardiac fibrosis: In vitro studies. Cardiovasc Res 1994; 28: 1863-1867.
22. Nicoletti A, Michel JB. Cardiac fibrosis and inflammation: Interaction with hemodynamic and hormonal factors. Cardiovasc Res 1999; 41: 532-543.
23. Campbell SE, Janicki JS, Matsubara BB, Weber KT. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevetion of scarring by amiloride. Am J Hypert 1993; 6: 487-495.
24. Robert V, Heymes C, Silvestre JS, Sabri A, Swynghedauw B, Delcayre C, Angiotensin AT1 receptor subtype as a cardiac target of aldosterone. Role in aldosterone-salt induced fibrosis. Hypertension 1999; 33: 981-986.
25. Sun Y, Weber KT. Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. J Lab Clin Med 1996; 127: 94-101.
26. Lariviere R, Deng LY, DAY R et al. Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat. J Mol Cell Cardiol 1995; 27: 2123-2131.
27. Fullerton MJ, Funder JW, Aldosterone regulates collagen output of cardiac fibroblasts by upregulation of endothelin receptors. Endocrin Soc Proc 1998; 93: 511.
28. Sun Y, Ratajska A, Weber KT. Bradykinin receptor and tissue ACE binding in myocardial fibrosis: Response to chronic angiotensin II administration: Attenuation by calcium channel blockade. J Mol Cell Cardiol 1995; 30: 475-483.
29. Ramires FJA, Sun Y, Weber KT. Myocardial fibrosis associated with aldosterone or angiotensin II administration: Attenuation bt calcium channel blockade. J Mol Cell Cardiol 1998; 30: 475-483.
30. Karam H, Heudes D, Hess P; Gonzales MF, Löffler BM, Clozel JP. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats. Cardiovasc Res 1996; 31: 287-295.
31. Sigusch HH, Campbell SE, Weber KT. Angiotensin II-induced myocardial fibrosis in rats: Role of nitric oxide, prostaglandins and bradykinin. Cardiovasc Res 1996; 31: 546-554.
32. Silvestre JS, Robert V, Escoubet B, Heymes C, Oubenaissa A, Desopper C, Swynghedauw B, Delcayre C. Different regulation of cardiac and renal corticosteroid receptors in aldosterone-treated rats: Effect of hypertension and glucocorticoids. J Mol Cell Cardiol 2000; 32: 1249-1263.
33. Horisberger JD, Rossier BC. Aldosterone regulation of gene transcription leading to control of ion transport. Hypertension 1992; 19: 221-227.
34. 3 exchanger in cultured neonatal rat cardiac cells. J Mol Cell Cardiol 1995; 27: 2521-2528.
35. Sato A, Liu JP, Funder JW. Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro. Endocrinology 1997, 138: 3410-3416.
36. Rossi GP, Saccheto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997; 95: 1471-1478.
37. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341:709-717.
38. Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Circulation 2000; 102: 2700-2706.
39. Modena MG, Aveta P, Menozzi A, Rossi R. Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after myocardial infarction. AM Heart J 2001; 141: 41-46.
40. MacFayden RJ, Barr CS, Struthers AD. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res 1997; 35: 30-34.
41. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B, Delcayre C. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998; 273: 4883-4891.
42. Thum T, Borlak J. Gene expression in the distinct regions of the heart. Lancet 2000; 355: 979-983.
43. Dell'Italia LI, Meng QC, Balcells E, Wei CC, Palmer R, Hageman GR, Durand J, Hankes GH, Oparil S. Compartimentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 1997; 100: 253-258.
44. Gomez-Sanchez CE, Zhou MY, Cozza EN et al. Aldosterone biosynthesis in the rat brain. Endocrinology 1997; 138: 3369-3373.
45. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R. Synthesis of corticosterone in the vascular wall. Endocrinology 1996; 135: 2283-2286.
46. Mizuno Y, Yoshimura M, Yasue H, Sakamot T, Ogawa H, Kugiyama K, Harada E, Nakayama M, Nakamura S, Ito T, Shimasaki Y, Saito Y, Nakao K. Aldosterone production is activated in failing ventricle in humans. Circulation 2001; 103: 72-78.
47. Silvestre JS, Heymes C, Oubenaissa A, Rober V, Aupetit-Faisant B, Carayon A, Swynghedauw B, Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction. Circulation 1999; 99: 2694-2701.
48. Weber KT. Recruitable ACE and tissue repair in the infarcted heart. J Renin Angio Aldo System 2000; 1: 295-303.
49. Dalle M, Giry J, Gay M. Delost P. Perinatal chages in plasma and adrenal corticosterone and aldosterone concentrations in the mouse. J Endocr 1978; 76: 303-309.
50. Mitani F, Mukai K, Ogawa T, Miyamoto H, Ishimura Y. Expression of cytochromes P450ado and P45011beta in rat adrenal gland durinlate gestational and neonatal stages. Steroids 1997; 62: 57-61.
51. Wotus C, Levay-Young BK, Rogers LM, Gomez-Sanchez CE, Engeland WC. Development of adrenal zonation in fetal rats defined by expression of aldosterone synthase and 11beta-hydroxylase. Endocrinology 1998; 139: 4397-4403.